MDXG
MiMedx Group Inc
Price:  
4.38 
USD
Volume:  
672,141.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDXG Relative Valuation

54.6%
Upside

As of 2026-03-14, the Relative Valuation of MiMedx Group Inc (MDXG) is 6.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.38 USD, the upside of MiMedx Group Inc based on Relative Valuation is 54.6%.

The range of the Relative Valuation is 4.66 - 8.21 USD.

Range Selected
Trailing P/E multiples 14.2x - 20.4x 17.5x
Forward P/E multiples 17.0x - 22.7x 21.6x
Fair Price 4.66 - 8.21 6.77
Upside 6.5% - 87.4% 54.6%
4.38 USD
Stock Price
6.77 USD
Fair Price

MDXG Relative Valuation - Historical P/E Data

Date P/E
2026-03-12 13.35
2026-03-11 13.90
2026-03-10 13.93
2026-03-09 13.75
2026-03-06 13.72
2026-03-05 14.48
2026-03-04 14.69
2026-03-03 14.51
2026-03-02 14.88
2026-02-27 14.91
2026-02-26 15.06
2026-02-25 16.10
2026-02-24 16.31
2026-02-23 16.25
2026-02-20 15.76
2026-02-19 15.85
2026-02-18 15.91
2026-02-17 15.73
2026-02-13 15.61
2026-02-12 15.52
2026-02-11 15.88
2026-02-10 15.76
2026-02-09 15.82
2026-02-06 15.70
2026-02-05 15.33
2026-02-04 15.58
2026-02-03 15.15
2026-02-02 15.52
2026-01-30 15.58
2026-01-29 15.67
2026-01-28 15.70
2026-01-27 16.16
2026-01-26 16.01
2026-01-23 16.04
2026-01-22 16.52
2026-01-21 16.25
2026-01-20 16.43
2026-01-16 16.52
2026-01-15 17.53
2026-01-14 17.35
2026-01-13 17.93
2026-01-12 18.29
2026-01-09 18.60
2026-01-08 19.24
2026-01-07 19.63
2026-01-06 19.51
2026-01-05 19.30
2026-01-02 19.75
2025-12-31 20.64
2025-12-30 20.91